Onda Coolwaves for the Double Chin: Microwave Science, Clinical Results, and Honest Limitations

A lot of patients come in saying the same thing: the jawline they used to have has softened, and a fullness under the chin appeared almost without warning. They haven't gained much weight. But looking in the mirror — or, worse, at a candid photo taken from the side — the clean angle between the jaw and neck is gone. Tilt the head down and a second chin folds into view. Submental fat is notoriously stubborn; it rarely responds to diet and exercise the way fat elsewhere in the body does. And because the skin in that area is thin and prone to laxity, it tends to sag as the underlying fat accumulates. Tightening the skin alone usually isn't enough. Neither is removing the fat alone — reduce the volume without tightening the overlying skin and the laxity can actually look worse. What patients in this situation want is both, without surgery. Onda Coolwaves is one non-invasive approach that attempts exactly that: using microwave energy to heat submental fat selectively while simultaneously stimulating the dermis above it. It's a newer technology with a coherent scientific rationale — and a limited evidence base that deserves an honest read. Here's what the mechanism, the clinical data, and the comparisons to Thermage and Ultherapy actually show.

What Is Onda Coolwaves, and How Does the Treatment Feel?

Onda Coolwaves is a device made by DEKA, an Italian medical laser and energy-based device company. The energy it delivers is microwave radiation — the same band of the electromagnetic spectrum used in a kitchen microwave oven, but controlled and calibrated for a precise medical purpose. A kitchen microwave floods food with energy indiscriminately; the Onda system delivers energy at 2.45 GHz with specific power density, depth targeting, and surface cooling designed to concentrate heating in the subdermal fat layer rather than on the skin surface.

The target is subcutaneous fat, not the skin itself. When microwave energy reaches the fat layer, it generates heat within the adipose tissue, causing fat cells to break down gradually over the weeks that follow. At the same time, thermal energy conducted upward into the dermis stimulates collagen contraction and remodeling. That dual action — fat reduction plus skin tightening — is what distinguishes Onda from devices that address only one component. Reducing submental volume without tightening the skin can leave patients looking deflated rather than defined; tightening skin over unaddressed fat rarely produces a clean jawline. The Onda approach attempts to tackle both simultaneously.

Treatment is non-invasive: no needles, no incisions. A handpiece is moved across the skin surface while the device emits microwave energy downward into the tissue. Integrated cooling continuously protects the skin surface from overheating so that thermal energy concentrates in the subcutaneous fat layer rather than burning the overlying skin. In practice, patients describe the sensation as deep, spreading warmth — different from the sharp, localized jolts that characterize Ultherapy, and different from the surface heat of some laser treatments. A single treatment area takes roughly ten minutes. Most published protocols involve multiple sessions; the studies that demonstrated measurable results used between two and six treatment sessions, not one.

One thing worth establishing upfront: Onda Coolwaves is a relatively recent entrant in the non-surgical contouring space. It does not have the depth of independent clinical literature that Thermage or Ultherapy has accumulated over a decade-plus of widespread use. The mechanism is scientifically credible, but the human evidence is still limited in scale, and much of what exists comes from research environments close to the manufacturer. That context matters when calibrating expectations — and this article will return to it, because honest framing of what is and isn't yet established is more useful than enthusiasm.

Why Does Microwave Energy Target Fat So Selectively?

The chart above captures the central claim: roughly 80% of delivered microwave energy is absorbed by subcutaneous fat, with only about 20% reaching surrounding tissue. The measurement reflects energy absorption by tissue layer, and the key figure is that 4-to-1 ratio favoring fat. It's worth noting upfront that this data originates from manufacturer technical documentation and associated analyses — not from a large, independent laboratory study — so the number should be understood as a manufacturer-reported specification rather than an independently replicated physical constant.

The physical principle underlying this selectivity is dielectric heating. When a microwave electromagnetic field passes through biological tissue, it causes polar molecules to oscillate rapidly, and the friction from that oscillation generates heat. Every tissue type responds differently: the critical variable is the dielectric constant — essentially how readily a given tissue absorbs electromagnetic energy at a specific frequency. At 2.45 GHz, adipose tissue has a dielectric constant that leads to substantially greater energy absorption than dermis or muscle. The same field, passed through the same region, generates more heat in fat than in the tissues above or below it.

Depth control adds another layer of selectivity. The skin surface is actively cooled throughout treatment, continuously removing heat from the epidermis even as microwave energy passes through it. The net result is that temperature rises most significantly at depth, in the subcutaneous fat — surface protected, target heated. The concept is analogous to how Ultherapy uses focused ultrasound to create thermal coagulation points deep in the tissue while leaving the skin above intact, though the energy type and precise mechanism differ considerably.

The important caveat: a physical principle that produces preferential fat heating does not automatically guarantee any specific clinical result. Individual anatomy varies substantially — the thickness and depth of submental fat, the quality and baseline laxity of overlying skin, and the fibrous architecture of the tissue all influence how microwave energy behaves in a real patient. And the 80/20 absorption figure, derived from manufacturer data, has not been replicated in large-scale independent tissue studies. The mechanism is credible; the magnitude of the selectivity claim warrants holding with appropriate skepticism until more independent work exists.

How Much Does Submental Laxity Actually Improve?

The graph above shows results from a study measuring skin laxity in the submental area before and after microwave treatment. The metric used is the SMSLG — Submental/Mandibular Skin Laxity Grade — rated on a 0-to-4 scale where lower scores mean less sagging. Before treatment, the average score was 3.6. At 12 weeks following the final session, it had dropped to 2.3 — roughly a 36% reduction, more than one full grade level on a four-point scale (Zappia et al., Lasers Med Sci 2025;40(1):28).

Now for the limitations, because they matter considerably here. This study enrolled ten patients. Ten. Results from a cohort that size can indicate a direction, but they cannot produce a reliable effect estimate applicable to a broad patient population. With small samples, a handful of unusually strong responders can move the mean substantially, and the absence of a control group means regression to the mean and assessor expectation effects cannot be ruled out. These aren't reasons to dismiss the finding — the direction of change is biologically plausible given the mechanism — but they are strong reasons not to treat the 36% figure as a settled benchmark.

The SMSLG itself introduces additional uncertainty. It is a clinician-graded visual scale, not an objective physical measurement. Trained graders evaluating the same patient can differ by a point or more depending on lighting, angle, and subjective judgment — which means a 1.3-point improvement on a 4-point scale sits uncomfortably close to inter-rater variability. The improvement is real in the reported data; interpreting its magnitude requires holding that measurement limitation in mind.

The protocol involved two treatment sessions, and results were measured at the 12-week mark. This means the data reflects that specific course of treatment — not a single session, and not outcomes beyond three months. Whether effects persist at six months or a year, whether additional sessions produce proportionally greater improvement, and how results differ across patient subtypes aren't answered by this study.

The honest read on this graph: it is a signal, not a proof. Microwave energy applied to the submental area appears to reduce clinically graded laxity over a 12-week window in the study population. That's a useful preliminary finding. But the study was small, the population narrow, and the research environment close to the device manufacturer. In clinical practice, I don't present this chart as a guarantee; I use it to explain that meaningful but modest improvement is biologically plausible and supported by early evidence — while being explicit that the foundation of that evidence is still limited.

What Do Patients Actually Think of the Results?

Objective laxity scores are one thing; whether patients feel the treatment was worth it is another. In a satisfaction study of microwave submental treatment, 70.2% of participants rated their outcome as satisfied or very satisfied (Salsi & Fusco, J Cosmet Dermatol 2022;21:5657). The measure is subjective self-report, and the headline number is that roughly seven in ten patients responded positively.

This study is larger than the laxity trial — 47 participants, treated across six sessions. A sample of 47 is still modest by the standards of a formal clinical trial, but it produces a more stable satisfaction estimate than a 10-person cohort. The 70% figure carries proportionally more weight.

The 30% who weren't satisfied is a meaningful minority, and worth pausing on. No non-invasive contouring treatment works for everyone, and Onda is no exception. Patient characteristics that tend to predict lower satisfaction in this category — high baseline expectations, minimal fat volume to address, or laxity primarily driven by deep structural changes rather than submental fat — are likely relevant here too, though the study doesn't stratify by these variables.

The subjective nature of satisfaction scores also introduces a systematic bias worth acknowledging. Patients who have committed to six treatment sessions invest time, money, and discomfort — and research consistently shows that investment can color self-reported outcomes in a positive direction. Without a control arm or blinded photographic grading, the satisfaction figure can't be cleanly separated from the effort invested. That's a standard methodological limitation across this entire category of aesthetic research, not something unique to this study.

Taken together with the laxity data, the picture is internally consistent: a clinician-graded scale shows improvement, and most patients perceive their outcome positively. Two imperfect metrics pointing in the same direction adds modest confidence that something real is happening. Neither study individually carries sufficient weight to make strong claims — but the convergence is meaningful context when counseling patients about realistic expectations.

The practical takeaway: Onda Coolwaves has a reasonable satisfaction profile in the early published data, with most people who complete a multi-session course reporting they are pleased with the outcome. That's a meaningful starting point — not a promise that seven out of ten patients you know will feel the same way, but a signal that the treatment lands well for the majority of appropriately selected patients.

Onda and Thermage and Ultherapy: Sorting Out the Differences

The question I hear most from patients exploring non-surgical options: how is this different from Thermage or Ultherapy? All three are non-invasive, all three use thermal energy to address facial and submental laxity, and all three are commonly offered in aesthetic practices. The differences come down to energy type and anatomical target.

Thermage FLX uses radiofrequency (RF) energy to heat the dermis broadly and uniformly. The mechanism is bulk tissue heating that partially denatures existing collagen, triggering immediate contraction and stimulating new collagen production over the following months. The primary clinical benefit is skin elasticity and surface tightening. Thermage doesn't carry a meaningful fat-reduction component — it's engineered to work within the dermal layer, not the subcutaneous fat that sits below it.

Ultherapy uses high-intensity focused ultrasound (HIFU) to deposit precise thermal coagulation points at depths reaching the superficial musculoaponeurotic system — the SMAS, the fibromuscular layer that plastic surgeons tighten during a facelift. Treating at the SMAS level is why Ultherapy holds FDA clearance for brow lifting and submental and neck laxity: it addresses the structural foundation of the lower face, not just the surface. Of the three technologies, Ultherapy works at the greatest depth and has the longest and most robust independent clinical track record for facial lifting.

Onda Coolwaves targets subcutaneous fat with microwave energy while secondarily warming the overlying dermis. If Thermage addresses the dermis and Ultherapy addresses the deep structural layer, Onda addresses the layer between them — the fat — while also stimulating the skin above. That positioning makes it most relevant where both excess fat and skin laxity coexist, which is precisely the anatomy of most double chins: a pocket of submental fat beneath thinning, increasingly lax skin.

The framing isn't which technology is best. These devices solve different anatomical problems, and no well-designed independent head-to-head trial has compared them directly. The right choice depends on what a patient's anatomy actually requires: primarily loose skin with good underlying volume → Thermage's dermal heating may be the more logical approach; deep structural sagging with good skin quality → Ultherapy's SMAS-level effect is more appropriate; submental fat plus mild-to-moderate laxity → Onda's dual mechanism is the most coherent fit. Many patients benefit from combining approaches, and the sequencing matters — something worth discussing with a provider experienced in all three.

For US patients evaluating the submental fat reduction category specifically: Kybella (deoxycholic acid injections, FDA-approved for submental fat) and CoolSculpting with the CoolMini applicator (cryolipolysis for submental fullness) are both non-surgical options commonly asked about. Both address fat but have no meaningful skin-tightening component — an important distinction if laxity is part of the concern.

Who Is a Good Candidate — and What Should You Watch Out For?

Onda Coolwaves fits a fairly specific patient profile: someone with visible submental fat combined with mild-to-moderate overlying skin laxity, where addressing the skin alone won't produce a clean jawline. This is the patient whose submental fullness persists despite weight management, whose neck-to-jaw angle has softened over time, and who wants meaningful refinement without surgery or injectable deoxycholic acid treatments.

Where results become more limited: patients with very little submental fat. If the primary concern is skin laxity with minimal fat volume, there isn't enough thermal target for the microwave energy to work on in a meaningful way. The fat-reduction arm of the treatment becomes negligible, and the skin-tightening effect alone may not justify the cost or the number of sessions relative to alternatives. In that scenario, a device that concentrates entirely on dermal collagen stimulation — Thermage FLX, or a fractional RF microneedling platform like Morpheus8 — is often a more efficient path. Accurate pre-treatment assessment of fat volume and skin laxity grade is not optional; it is what determines whether any device in this category is the right tool for a specific patient.

The logistics are low-barrier. Sessions take roughly ten minutes per area, there's no true recovery period, and patients return to normal activities immediately. The sensation — deep warmth rather than sharp pain — is generally tolerated without topical anesthesia, though some providers offer a numbing cream for patient comfort. Multiple sessions are the norm, not the exception: the studies that showed measurable improvement used protocols of two to six treatments. This is not a single-session treatment; the effect builds cumulatively, and that timeline and financial commitment should be understood clearly before starting.

Side effects to be aware of: transient redness and a warm, flushed sensation immediately after treatment are expected and typically resolve within hours. Mild swelling or bruising can occur. Less commonly, patients notice a firm nodule or area of localized induration in the treated fat — this reflects localized inflammation and the fat remodeling process and typically softens over several weeks. If a nodule is painful, enlarging, or accompanied by visible skin changes, it warrants clinical evaluation rather than watchful waiting. Avoiding direct pressure or friction over the treated area for a few days after each session is sensible advice.

Absolute contraindications: pregnancy, active infection in the treatment field, and implanted electronic devices — pacemakers, neurostimulators, cochlear implants — or metal hardware in the treatment area. Microwave energy interacts with implanted electronics and metal in ways that can cause harm; this screening is non-negotiable and must occur before any treatment session.

A final word on expectations. Onda Coolwaves is a reasonable option for patients whose anatomy fits the indication and who are prepared for gradual, moderate improvement rather than dramatic transformation. The available clinical data supports a real but modest effect — a jawline that reads as noticeably cleaner and more defined, not a jawline that looks surgically lifted. Setting that expectation clearly before the first session is, in my experience, the single most influential factor in whether a patient ultimately feels the treatment was worthwhile. The technology is legitimate; the evidence base is early-stage; the realistic goal is refinement, not reinvention.